Perphenazine
- Perphenazine的基本解释
-
-
夹二氮蒽, 丕芬那辛, 过非那嗪, 过二苯嗪
- 更多网络例句与Perphenazine相关的网络例句 [注：此内容来源于网络，仅供参考]
-
Objective To establish a rapid and precise continuous flow-injection chemiluminescence method for the determination of perphenazine.
目的建立快速测定奋乃静的流动注射化学发光新方法。
-
Methods: Sixty three patients with alcohol induced mental disorders were recruited in the study, with 32 treated with tiapride 200 mgd-1±s 12 mgd-1 and 31 with perphenazine 16.0 mgd^(-1)±s 3.4 mgd^(-1) for 8 weeks.
共纳入63例酒精所致精神障碍患者，其中泰必利组32例，剂量为200mgd^(-1)±s12mgd^(-1)；奋乃静组为31例，剂量为16.0mgd^(-1)±s3.4mgd^(-1)；疗程共8周。
-
The average recoveries were 60.2%~125% and 64.5%~126% for the drugs in plasma and urine except those of perphenazine, thioridazine and chloropromazine in plasma were 37.6%~57.5%, 36.3%~48.3%, 52.4%~67.4%, respectively; trazodone and diazepam in urine were 100%~142% and 108%~177%, respectively. The relative standard deviations of all the drugs in plasma and urine were within 0.8%~26% and 2.6%~18%(n=6), respectively. The detection limits of the 4 barbitals ranged from 20 to 100 mg/L and those of the other drugs ranged from 0.05 to 2.0 mg/L.
血浆样品中待测组分的加标回收率除了奋乃静、硫利哒嗪和氯丙嗪的分别为37.6%～57.5%， 36.3%～48.3%和52.4%～67.4%外，尿液样品中待测组分的加标回收率除了曲唑酮和地西泮的分别为100%～142%和108%～177%外，血浆和尿液中其余待测组分的加标回收率分别为60.2%～125%和64.5%～126%，相对标准偏差分别为0.8%～26%和2.6%～18%(n=6)；除了巴比妥类药物的检出限为20～100 mg/L外，其余药物的检出限均为0.05～2.0 mg/L。
- 更多网络解释与Perphenazine相关的网络解释 [注：此内容来源于网络，仅供参考]
-
phenobarbital, luminal：本巴比妥,鲁米那
perphenazine 奋乃静 | phenobarbital, luminal 本巴比妥,鲁米那 | Analgesics 镇痛药
-
phenobarbital, luminal：本巴比妥,鲁米那Analgesics 镇痛药
perphenazine 奋乃静 | phenobarbital, luminal 本巴比妥,鲁米那Analgesics 镇痛药 | codeine phosphate 磷酸可待因
-
perpetual motion：永久运动
peroxydisulfuric acid 过硫酸 | perpetual motion 永久运动 | perphenazine 佩吩嗪